Literature DB >> 33704708

Analysis of Melanoma Cell Glutamine Metabolism by Stable Isotope Tracing and Gas Chromatography-Mass Spectrometry.

David A Scott1.   

Abstract

Glutamine is a major substrate for biosynthesis. It contributes to multiple pathways required for cell proliferation, supports antioxidant defense via glutathione synthesis, and sustains the tricarboxylic acid (TCA) cycle through anaplerosis. Glutamine-fueled anaplerosis and related biosynthesis can be studied in detail in melanoma using stable isotope (13C) labeling followed by gas chromatography-mass spectrometry (GC-MS) analysis of metabolite amounts and labeling. Detailed protocols for the assay of polar metabolites (including amino acids, TCA cycle, and glycolysis metabolites) and fatty acids by these methods following cell treatment with 13C-glutamine or 13C-glucose are presented.

Entities:  

Keywords:  Amino acids; Fatty acids; GC-MS; Glutamine; Glycolysis; Melanoma; Metabolite quantification; Stable-isotope tracing; Tricarboxylic acid cycle

Mesh:

Substances:

Year:  2021        PMID: 33704708     DOI: 10.1007/978-1-0716-1205-7_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

1.  Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells.

Authors:  Deven Patel; Deepak Menon; Elyssa Bernfeld; Victoria Mroz; Sampada Kalan; Diego Loayza; David A Foster
Journal:  J Biol Chem       Date:  2016-02-26       Impact factor: 5.157

Review 2.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

3.  Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.

Authors:  Tomoyuki Mashimo; Kumar Pichumani; Vamsidhara Vemireddy; Kimmo J Hatanpaa; Dinesh Kumar Singh; Shyam Sirasanagandla; Suraj Nannepaga; Sara G Piccirillo; Zoltan Kovacs; Chan Foong; Zhiguang Huang; Samuel Barnett; Bruce E Mickey; Ralph J DeBerardinis; Benjamin P Tu; Elizabeth A Maher; Robert M Bachoo
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

4.  Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation.

Authors:  Min Pan; Michael A Reid; Xazmin H Lowman; Rajan P Kulkarni; Thai Q Tran; Xiaojing Liu; Ying Yang; Jenny E Hernandez-Davies; Kimberly K Rosales; Haiqing Li; Willy Hugo; Chunying Song; Xiangdong Xu; Dustin E Schones; David K Ann; Viviana Gradinaru; Roger S Lo; Jason W Locasale; Mei Kong
Journal:  Nat Cell Biol       Date:  2016-09-12       Impact factor: 28.824

5.  Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting.

Authors:  H Furkan Alkan; Katharina E Walter; Alba Luengo; Corina T Madreiter-Sokolowski; Sarah Stryeck; Allison N Lau; Wael Al-Zoughbi; Caroline A Lewis; Craig J Thomas; Gerald Hoefler; Wolfgang F Graier; Tobias Madl; Matthew G Vander Heiden; Juliane G Bogner-Strauss
Journal:  Cell Metab       Date:  2018-08-16       Impact factor: 31.373

6.  Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma.

Authors:  Boris Ratnikov; Pedro Aza-Blanc; Ze'ev A Ronai; Jeffrey W Smith; Andrei L Osterman; David A Scott
Journal:  Oncotarget       Date:  2015-04-10

7.  Vemurafenib resistance reprograms melanoma cells towards glutamine dependence.

Authors:  Jenny E Hernandez-Davies; Thai Q Tran; Michael A Reid; Kimberly R Rosales; Xazmin H Lowman; Min Pan; Gatien Moriceau; Ying Yang; Jun Wu; Roger S Lo; Mei Kong
Journal:  J Transl Med       Date:  2015-07-03       Impact factor: 5.531

8.  HMDB 4.0: the human metabolome database for 2018.

Authors:  David S Wishart; Yannick Djoumbou Feunang; Ana Marcu; An Chi Guo; Kevin Liang; Rosa Vázquez-Fresno; Tanvir Sajed; Daniel Johnson; Carin Li; Naama Karu; Zinat Sayeeda; Elvis Lo; Nazanin Assempour; Mark Berjanskii; Sandeep Singhal; David Arndt; Yonjie Liang; Hasan Badran; Jason Grant; Arnau Serra-Cayuela; Yifeng Liu; Rupa Mandal; Vanessa Neveu; Allison Pon; Craig Knox; Michael Wilson; Claudine Manach; Augustin Scalbert
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

9.  Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells.

Authors:  Franziska Baenke; Barbara Chaneton; Matthew Smith; Niels Van Den Broek; Kate Hogan; Haoran Tang; Amaya Viros; Matthew Martin; Laura Galbraith; Maria R Girotti; Nathalie Dhomen; Eyal Gottlieb; Richard Marais
Journal:  Mol Oncol       Date:  2015-08-20       Impact factor: 6.603

10.  Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors.

Authors:  Raeeka Khamari; Anne Trinh; Pierre Elliott Gabert; Paola Corazao-Rozas; Samuel Riveros-Cruz; Stephane Balayssac; Myriam Malet-Martino; Salim Dekiouk; Marie Joncquel Chevalier Curt; Patrice Maboudou; Guillaume Garçon; Laura Ravasi; Pierre Guerreschi; Laurent Mortier; Bruno Quesnel; Philippe Marchetti; Jerome Kluza
Journal:  Cell Death Dis       Date:  2018-02-27       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.